A product-focused biotechnology company developing peripherally acting treatments for metabolic disease, based on research into brown fat biology and selective insulin sensitivity
A product-focused biotechnology company developing peripherally acting treatments for metabolic disease, based on research into brown fat biology and selective insulin sensitivity. Its pipeline targets conditions including Type 2 diabetes and obesity.